Mentz Robert J, Hernandez Adrian F, Berdan Lisa G, Rorick Tyrus, O'Brien Emily C, Ibarra Jenny C, Curtis Lesley H, Peterson Eric D
From Duke Clinical Research Institute, Durham, NC (R.J.M., A.F.H., L.G.B., T.R., E.C.O'B., J.C.I., L.H.C., E.D.P.); and Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC (R.J.M., AF.H., E.C.O'B., E.D.P.).
Circulation. 2016 Mar 1;133(9):872-80. doi: 10.1161/CIRCULATIONAHA.115.019902.
Randomized, clinical trials are commonly regarded as the highest level of evidence to support clinical decisions. Good Clinical Practice guidelines have been constructed to provide an ethical and scientific quality standard for trials that involve human subjects in a manner aligned with the Declaration of Helsinki. Originally designed to provide a unified standard of trial data to support submission to regulatory authorities, the principles may also be applied to other studies of human subjects. Although the application of Good Clinical Practice principles generally led to improvements in the quality and consistency of trial operations, these principles have also contributed to increasing trial complexity and costs. Alternatively, the growing availability of electronic health record data has facilitated the possibility for streamlined pragmatic clinical trials. The central tenets of Good Clinical Practice and pragmatic clinical trials represent potential tensions in trial design (stringent quality and highly efficient operations). In the present article, we highlight potential areas of discordance between Good Clinical Practice guidelines and the principles of pragmatic clinical trials and suggest strategies to streamline study conduct in an ethical manner to optimally perform clinical trials in the electronic age.
随机临床试验通常被视为支持临床决策的最高证据级别。已制定了《药物临床试验质量管理规范》指南,以便为涉及人类受试者的试验提供符合《赫尔辛基宣言》的伦理和科学质量标准。这些原则最初旨在提供统一的试验数据标准,以支持向监管机构提交资料,也可应用于其他关于人类受试者的研究。虽然应用《药物临床试验质量管理规范》原则通常会提高试验操作的质量和一致性,但这些原则也导致试验复杂性和成本增加。另外,电子健康记录数据的日益普及为简化务实的临床试验提供了可能。《药物临床试验质量管理规范》和务实临床试验的核心原则在试验设计中(严格的质量和高效的操作)存在潜在矛盾。在本文中,我们强调了《药物临床试验质量管理规范》指南与务实临床试验原则之间可能存在不一致的领域,并提出了以符合伦理的方式简化研究实施的策略,以便在电子时代以最佳方式开展临床试验。